Aurolife Pharma, LLC recalls Fexofenadine Hydrochrloride Tablets USP, 180 mg, 100-count bottle, Distributed by: Aurohealth LLC., 2572 Brunswick Pike,
Recalled September 25, 2019 · FDA recall D-1864-2019 · Aurolife Pharma
Hazard
Failed Impurities/Degradation Specifications · FDA Class II
Units
8,240 bottles
Sold at
Nationwide in the USA
Description
Failed Impurities/Degradation Specifications
Product
Fexofenadine Hydrochrloride Tablets USP, 180 mg, 100-count bottle, Distributed by: Aurohealth LLC., 2572 Brunswick Pike, Lawrenceville, NJ 08648, NDC 58602-711-21
Manufacturer(s)
Aurolife Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →